Abstract:Abstract Background Combined pulmonary fibrosis and emphysema (CPFE) is a heterogeneous clinico-radiological syndrome without a consensus definition. There are limited data on the relation between the amount of parenchymal fibrosis and prognosis. In this study, we assessed the prognostic implications of the extent of fibrosis assessed by an automated quantitative computed tomography (CT) technique and the radiological and functional change over time in patients with a broad spectrum of fibrotic interstitial lung diseases (ILDs) encountered in a real-world setting. Methods We conducted a single-centre, retrospective study of 228 consecutive patients with CPFE, encountered from 2007 to 2015 at Kameda Medical Center, Chiba, Japan. We investigated the prognostic value of automated CT fibrosis quantification and the subsequent course of CPFE. Results Among 228 patients with CPFE, 89 had fibrosis affecting < 5% of their lungs, 54 had 5 to < 10% fibrosis, and 85 had ≥ 10% fibrosis at the time of diagnosis. Lower volume of fibrosis correlated with lower rates of mortality and acute exacerbation ( p < 0.001). In particular, among those with < 5% fibrosis, only 4.5% died and none experienced acute exacerbation during follow-up, whereas 57.6% and 29.4% of those with ≥ 10% fibrosis experienced death and acute exacerbation, respectively. Although, the ≥ 10% fibrosis group had the poorest overall survival as well as the highest incidence of acute exacerbation, the incidence of decline in pulmonary function tests, change per year in total lung volume, and progression of fibrosis on chest CT was highest in the 5 to < 10% fibrosis group. The Cox proportional hazard model for CPFE progression (defined by composite criteria of death, acute exacerbation, and decline in forced vital capacity or diffusing capacity) showed fibrosis proportion was a risk factor independent of age, sex, smoking pack-years, the Charlson Comorbidity Index, lung cancer, connective tissue disease, and idiopathic pulmonary fibrosis. Conclusions Less severe (< 5%) fibrosis at baseline was associated with disease stability and better prognosis compared to more severe fibrosis in CPFE occurring with fibrotic ILDs. Further studies including a validation cohort will be needed. Trial Registration Retrospectively registered.

Computed Tomography Characterization of Emphysema in Combined Pulmonary Fibrosis and Emphysema (CPFE) and Its Correlation with Lung Cancer with Comparison to Chronic Obstructive Pulmanory Disease (COPD)

Combined Pulmonary Fibrosis and Emphysema Syndrome

Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis

Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema Revisited with the 2015 World Health Organization Classification of Lung Tumors.

Meta-analysis: clinical features and treatments of lung cancer in combined pulmonary fibrosis and emphysema

Clinical characteristics and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema: a systematic review and meta-analysis of 13 studies.

A Preliminary Study on the Relationship Between High-Resolution Computed Tomography and Pulmonary Function in People at Risk of Developing Chronic Obstructive Pulmonary Disease

Automated computed tomography quantification of fibrosis predicts prognosis in combined pulmonary fibrosis and emphysema in a real-world setting: a single-centre, retrospective study

Quantitative Imaging Methods in Combined Pulmonary Fibrosis and Emphysema

Correlations of Computed Tomography Measurement of Distal Pulmonary Vascular Pruning with Airflow Limitation and Emphysema in COPD Patients

Clinical Analysis of Chronic Obstructive Pulmonary Disease with Pulmonary Interstitial Fibrosis

Emphysema And Bronchiectasis In Copd Patients With Previous Pulmonary Tuberculosis: Computed Tomography Features And Clinical Implications

Analysis of clinical characteristics and prognosis of lung cancer patients with CPFE or COPD: a retrospective study

Label-free assay for the assessment of nonspecific binding of positron emission tomography tracer candidates.

Clinical Analysis of Chronic Obstructive Pulmonary Disease with Pulmonary Interstitial Fiberosis

COMPUTED TOMOGRAPHY FEATURES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASSOCIATED WITH LUNG CANCER

Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease

Correlation between quantitative multi-detector computed tomography lung analysis and pulmonary function tests in chronic obstructive pulmonary disease patients

Multi-sfice CT pulmonary function evaluation in emphysema

Impact of Emphysema Heterogeneity on Pulmonary Function.

Quantitative Evaluation of Chronic Obstructive Pulmonary Disease and Risk Prediction of Acute Exacerbation by High-Resolution Computed Tomography